ACETYLCYSTEINE
Generic: ACETYLCYSTEINE
Somerset TherapeuticsManufacturer
INTRAVENOUSRoute
ACETYLCYSTEINEActive Substance
2024-06-07Original Approval
ACETYLCYSTEINE is FDA application ANDA218397, sponsored by SOMERSET THERAPS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2026-07-24
ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7604-01), and b) 25xPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, gla
Class II2026-07-24
ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7504-01), and b) 25xPresence of Particulate Matter: Product contaminated with particulate matter identified as hair, gla
Top Reported Reactions
1
DYSPNOEA
791 reports
2
OFF LABEL USE
679 reports
3
DRUG INEFFECTIVE
667 reports
4
PNEUMONIA
651 reports
5
PYREXIA
518 reports
6
FATIGUE
468 reports
7
NAUSEA
450 reports
8
DIARRHOEA
379 reports
9
VOMITING
340 reports
10
DEATH
332 reports